Gynecologic Cancer InterGroup (GCIG) Consensus Review for Cervical Adenocarcinoma

被引：38

作者：

Fujiwara, Hiroyuki ^{[1
]}

Yokota, Harushige ^{[2
]}

Monk, Bradley ^{[3
]}

Treilleux, Isabelle ^{[4
]}

Devouassoux-Shisheboran, Mojgan ^{[5
]}

Davis, Alison ^{[6
,7
]}

Kim, Jae-Weon ^{[8
]}

Mahner, Sven ^{[9
]}

Stany, Michael ^{[10
]}

Pignata, Sandro ^{[11
]}

Ray-Coquard, Isabelle ^{[4
]}

Fujiwara, Keiichi ^{[12
]}

机构：

[1] Jichi Med Univ, Shimono City, Japan

[2] Saitama Canc Ctr, Saitama, Japan

[3] Univ Arizona, Phoenix, AZ USA

[4] Ctr Leon Berard, F-69373 Lyon, France

[5] Hosp Civils Lyon, Lyon, France

[6] Canberra Hosp, Canberra, ACT, Australia

[7] ANZGOG, Camperdown, NSW, Australia

[8] Seoul Natl Univ, Coll Med, Seoul, South Korea

[9] Univ Klinikum Hamburg Eppendorf, Hamburg, Germany

[10] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA

[11] Ist Nazl Tumori Fdn G Pascale IRCCS, Milan, Italy

[12] Saitama Med Univ, Int Med Ctr, Hidaka City, Japan

来源：

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2014年 / 24卷 / 09期

关键词：

Cervical Cancer; Adenocarcinoma; Pathology; Staging; Clinical management; SQUAMOUS-CELL CARCINOMA; UTERINE CERVIX; ONCOLOGY-GROUP; COMBINATION CHEMOTHERAPY; RADICAL SURGERY; PHASE-III; NEOADJUVANT CHEMOTHERAPY; PROGNOSTIC-FACTORS; UNITED-STATES; EARLY-STAGE;

D O I：

10.1097/IGC.0000000000000263

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Cervical adenocarcinoma is known to be less common than squamous cell carcinoma of the cervix comprising approximately 25% of all cervical carcinomas. Differences in associated human papillomavirus types, patterns of spread, and prognosis call for treatments that are not always like those for squamous cancers. In this review, we report a consensus developed by the Gynecologic Cancer InterGroup surrounding cervical adenocarcinoma for epidemiology, pathology, treatment, and unanswered questions. Prospective clinical trials are needed to help develop treatment guidelines.

引用

页码：S96 / S101

页数：6

共 50 条

[31] A comparison of the prognosis between adenocarcinoma and squamous cell carcinoma in stage IB-IIA cervical cancer
Xie, Xiuzhen
Song, Kun
Cui, Baoxia
Jiang, Jie
Yang, Xingsheng
Kong, Beihua
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (03) : 522 - 531
[32] Comparison of adenocarcinoma and adenosquamous carcinoma in patients with early-stage cervical cancer after radical surgery
Baek, Min-Hyun
Park, Jeong-Yeol
Kim, Daeyeon
Suh, Dae-Shik
Kim, Jong-Hyeok
Kim, Yong-Man
Kim, Young-Tak
Nam, Joo-Hyun
GYNECOLOGIC ONCOLOGY, 2014, 135 (03) : 462 - 467
[33] Adenocarcinoma histology is a poor prognostic factor in locally advanced cervical cancer
Jonska-Gmyrek, Joanna
Gmyrek, Leszek
Zolciak-Siwinska, Agnieszka
Kowalska, Maria
Kotowicz, Beata
CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (04) : 595 - 601
[34] Impact of histological subtype on survival of patients with surgically-treated stage IA2-IIB cervical cancer: Adenocarcinoma versus squamous cell carcinoma
Mabuchi, Seiji
Okazawa, Mika
Matsuo, Koji
Kawano, Mahiru
Suzuki, Osamu
Miyatake, Takashi
Enomoto, Takayuki
Kamiura, Shoji
Ogawa, Kazuhiko
Kimura, Tadashi
GYNECOLOGIC ONCOLOGY, 2012, 127 (01) : 114 - 120
[35] Treatment options in recurrent cervical cancer (Review)
Gadducci, Angiolo
Tana, Rerta
Cosio, Stefania
Cionini, Luca
ONCOLOGY LETTERS, 2010, 1 (01) : 3 - 11
[36] Less radical surgery for early-stage cervical cancer: a systematic review
Wu, Jenny
Logue, Teresa
Kaplan, Samantha J.
Melamed, Alexander
Tergas, Ana I.
Khoury-Collado, Fady
Hou, June Y.
St Clair, Caryn M.
Hershman, Dawn L.
Wright, Jason D.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2021, 224 (04) : 348 - 358
[37] Efficacy and Safety of Immunotherapy for Cervical Cancer-A Systematic Review of Clinical Trials
Schmidt, Mona W.
Battista, Marco J.
Schmidt, Marcus
Garcia, Monique
Siepmann, Timo
Hasenburg, Annette
Anic, Katharina
CANCERS, 2022, 14 (02)
[38] How to optimize and evaluate diversity in gynecologic cancer clinical trials: statements from the GCIG Barcelona Meeting
Sehouli, Jalid
Boer, Jolijn
Brand, Alison H.
Oza, Amit M.
O'Donnell, Jennifer
Bennett, Katherine
Glaspool, Ros
Lee, Chee Khoon
Ethier, Josee-Lyne
Harter, Philipp
Seebacher-Shariat, Veronika
Chang, Ting-Chang
Cohen, Paul A.
van Gorp, Toon
Chavez-Blanco, Adriana
Welch, Stephen
Hranovska, Hanna
O'Toole, Sharon
Lok, Christianne A. R.
Madariaga, Ainhoa
Rauh-Hain, Jose Alejandro
Perez Fidalgo, Alejandro
Tan, David
Michels, Judith
Pothuri, Bhavana
Fujiwara, Noriko
Rosengarten, Ora
Nishio, Hiroshi
Kim, Se Ik
Mukopadhyay, Asima
Piovano, Elisa
Cecere, Sabrina Chiara
Kohn, Elise C.
Mukherjee, Uma
Nasser, Sara
Lindemann, Kristina
Croke, Jennifer
Chen, Xiaojun
Geissler, Franziska
Bookman, Michael A.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (11) : 1677 - 1684
[39] Comparison of the outcome between cervical adenocarcinoma and squamous cell carcinoma patients with adjuvant radiotherapy following radical surgery: SGSG/TGCU Intergroup Surveillance
Shimada, Muneaki
Nishimura, Ryuichiro
Nogawa, Takamitsu
Hatae, Masayuki
Takehara, Kazuhiro
Yamada, Hidekazu
Kurachi, Hirohisa
Yokoyama, Yoshihito
Sugiyama, Toru
Kigawa, Junzo
MOLECULAR AND CLINICAL ONCOLOGY, 2013, 1 (04) : 780 - 784
[40] Open versus minimally invasive radical hysterectomy for early cervical cancer: A two-center retrospective cohort study with pathologic review of usual-type adenocarcinoma and adenosquamous carcinoma
Kim, Yeorae
Kim, Se Ik
Kim, Hyojin
Lee, Maria
Kim, Hee Seung
Kim, Kidong
Chung, Hyun Hoon
No, Jae Hong
Kim, Yong Beom
Kim, Jae-Weon
Park, Noh Hyun
Song, Yong-Sang
Lee, Cheol
Suh, Dong Hoon
GYNECOLOGIC ONCOLOGY, 2022, 167 (01) : 28 - 36

← 1 2 3 4 5 →